Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: May 28, 2026

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

Modeling red blood cell survival data.

Julia Korell¹, Frederiek E Vos, Carolyn V Coulter

¹School of Pharmacy, University of Otago, Dunedin, New Zealand. julia.korell@otago.ac.nz

Journal of Pharmacokinetics and Pharmacodynamics

|October 15, 2011

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Population Pharmacokinetics and Exposure-Response Model-Based Bayesian Extrapolation of FVC-Based Efficacy Endpoints From Adults to Pediatric Patients Receiving Nintedanib.

CPT: pharmacometrics & systems pharmacology·2025

Same author

Exposure-Efficacy Meta-Model of Nintedanib in Adult Patients With Chronic Fibrosing Interstitial Lung Diseases.

CPT: pharmacometrics & systems pharmacology·2025

Same author

Urinary proteomic profiling to identify early biomarkers of non-diabetic chronic kidney disease.

Clinical kidney journal·2025

Same author

Meropenem and piperacillin/tazobactam optimised dosing regimens for critically ill patients receiving renal replacement therapy.

Intensive care medicine·2025

Same author

A Pharmacometric Workflow for Resolving Model Instability in Model Use-Reuse Settings.

CPT: pharmacometrics & systems pharmacology·2025

Same author

Evaluation of an optimized intermittent vancomycin dosing regimen in infants.

The Journal of antimicrobial chemotherapy·2025

Red blood cell (RBC) survival is significantly reduced in patients with chronic kidney disease (CKD). This study found that random destruction, not accelerated aging, best explains the decreased RBC survival in CKD patients undergoing hemodialysis.

Area of Science:

Nephrology
Hematology
Biostatistics

Background:

Anemia is a common complication of chronic kidney disease (CKD).
Reduced red blood cell (RBC) survival contributes to anemia in CKD, alongside erythropoietin deficiency.
The precise mechanisms driving altered RBC survival in CKD remain unclear.

Purpose of the Study:

To investigate the mechanisms underlying reduced RBC survival in patients with CKD.
To compare RBC survival between CKD patients undergoing hemodialysis and healthy controls.
To apply a statistical model to analyze RBC survival parameters.

Main Methods:

Utilized a previously developed statistical model for RBC survival analysis.
Applied the model to clinical data from 14 CKD patients on hemodialysis and 14 healthy controls.

More Related Videos

Optimized Staining and Proliferation Modeling Methods for Cell Division Monitoring using Cell Tracking Dyes

Optimized Staining and Proliferation Modeling Methods for Cell Division Monitoring using Cell Tracking Dyes

Published on: December 13, 2012

Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins

Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins

Published on: March 17, 2023

Related Experiment Videos

Last Updated: May 28, 2026

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Monitoring Neuronal Survival via Longitudinal Fluorescence Microscopy

Published on: January 19, 2019

Optimized Staining and Proliferation Modeling Methods for Cell Division Monitoring using Cell Tracking Dyes

Optimized Staining and Proliferation Modeling Methods for Cell Division Monitoring using Cell Tracking Dyes

Published on: December 13, 2012

Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins

Immunostaining-Based Detection of Dynamic Alterations in Red Blood Cell Proteins

Published on: March 17, 2023

Employed radioactive chromium (⁵¹Cr) for random RBC labeling and analyzed data using two-stage and full population approaches.

Main Results:

The statistical model indicated that random destruction, rather than accelerated senescence, better explained RBC survival in both CKD patients and controls.
RBC survival was significantly reduced in CKD patients compared to healthy controls.
A relative reduction in RBC survival of 20-30% was observed in CKD patients, depending on the analysis method.

Conclusions:

Altered RBC survival, primarily due to increased random destruction, is a significant factor in the anemia associated with chronic kidney disease.
The findings highlight the importance of understanding RBC kinetics in managing anemia in CKD patients.
Further research may explore specific factors contributing to increased random RBC loss in CKD.